FindTrial
Sign In

Comparing Two Anesthesia Combinations During Head and Neck Cancer Surgery: Nalbuphine vs. Fentanyl

Comparative analysis of intra-operative hemodynamics with Nalbuphine -dexmedetomidine vs. fentanyl-dexmedetomidine in head and neck oncosurgery- an observation study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/05/087785
Enrollment
64
Registered
2025-05-28
Start date
Unknown
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C00-C14- Malignant neoplasms of lip, oral cavity and pharynx

Interventions

Intervention1: Group N: inj. Nalbuphine 0.2 mg/kg will be given slowly over 10 minutes Intervention2: Nil: Nil Control Intervention1: Group F: inj. Fentanyl 2 mcg/kg will be given over 10 minutes

Sponsors

Shree krishna hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: American society of Anesthesiologists (ASA) Grade 2 to 3 Age 18 to 65 yrs. Patients undergoing elective head and neck cancer surgery under general anesthesia

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
To compare intraoperative hemodynamics (heart rate, Systolic blood pressure (SBP), Mean arterial pressure(MAP) with iv nalbuphine or iv fentanyl with dexmedetomidine in head and neck onco-surgeriesTimepoint: 1 year from approval of CTRI—

Secondary

MeasureTime frame
To assess the total consumption of inhalation anesthetic drug Number of additional intraoperative analgesic requirement Post reversal time to open eye on verbal command Post reversal sedation Post op pain assessment Timepoint: till 1 year of gaining approval from CTRI—

Countries

India

Contacts

Public ContactSherashiya Abhishek Rajeshbhai

Shri Krishna Hospital & Pramukhswami Medical College

abhisheksherasiya111@gmail.com7043412344

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026